3 completed. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 3 |
Follow Asarina Pharma: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Explore the Effect of Sepranolone in Tourette Syndrome Sepranolone - Tourette Syndrome, Tourette Syndrome in Adolescence | Phase 2 | Completed | Asarina Pharma | 26 | 2022-02-16 | 2023-06-09 |
| A Study Investigating the Efficacy and Safety of Sepranolone in Women With Menstrual Migraine Sepranolone injection low dose, Sepranolone injection high dose, Placebo injection - Menstrual Migraine | Phase 2 | Completed | Asarina Pharma | 86 | 2019-08-27 | 2021-07-26 |
| A Study of Efficacy and Safety of Sepranolone (UC1010) in Patients With Premenstrual Dysphoric Disorder (PMDD) Sepranolone (UC1010) low dose, Sepranolone (UC1010) high dose, Placebo - Premenstrual Dysphoric Disorder | Phase 2 | Completed | Asarina Pharma | 475 | 2018-04-20 | 2020-10-28 |
Premenstrual Dysphoric Disorder (1) · Tourette Syndrome (1)
Pregnanolone (3)
Sweden (2) · Denmark (1) · Finland (1) · Germany (1) · Poland (1) · United Kingdom (1)
Nanette Debes, MD (1) · Shaughn O'Brien, MD (1)